Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.

El Kasmi, K C; Fillon, S; Theisen, D M; Hartter, H; Brons, N H; Muller, C P

El Kasmi, K C; Fillon, S; Theisen, D M; Hartter, H; Brons, N H; Muller, C P.

Affiliation

El Kasmi KC; Laboratoire National de Santé, PO Box 1102, L-1011 Luxembourg, Universität Tübingen, D-72076 Tübingen, Germany.

J Gen Virol ; 81(Pt 3): 729-35, 2000 Mar.

Article in En | MEDLINE | ID: mdl-10675410

Subject(s)

Antibodies, Viral/blood; Measles Vaccine/pharmacology; Measles virus/immunology; Vaccines, Synthetic/pharmacology; Amino Acid Sequence; Amino Acid Substitution; Animals; Antigens, Viral/genetics; B-Lymphocytes/immunology; Cross Reactions; Epitopes/genetics; Female; Humans; Immunization, Passive; Infant; Male; Measles Vaccine/immunology; Measles virus/genetics; Measles virus/isolation & purification; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neutralization Tests; T-Lymphocytes/immunology; Vaccines, Synthetic/immunology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Measles Vaccine / Vaccines, Synthetic / Measles virus / Antibodies, Viral Limits: Animals / Female / Humans / Infant / Male Language: En Journal: J Gen Virol Year: 2000 Document type: Article Affiliation country: Germany Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links